Clinical Trials Directory

Trials / Completed

CompletedNCT00822510

Telephone Counseling: Men With Prostate Cancer & Partners

Telephone Counseling With Men With Prostate Cancer and Partners

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
79 (actual)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to test a telephone delivered educational support program versus an education only program for improving symptom management and quality of life in men with prostate cancer and their partners.

Detailed description

Eligibility Criteria for men: receiving treatment for prostate cancer,over 21 years of age, English speaking, have access to and ability to talk on the phone and have a partner willing to participate in the study. Participants can live anywhere in the United States because the intervention is telephone delivered. Partners can be anyone the man selects (friend or relative) who is over 21 years of age, English speaking and has access to or ability to speak on the phone. Men and their partners will be assigned to one of two groups. Each survivor will receive 8 telephone calls over an 8-week period for about 30 minutes each. Each partner will receive 4 telephone calls every other week for about 30 minutes each. We will ask everyone to complete a baseline assessment over the telephone, after the 8 weeks, and then again about 8 weeks after the second assessment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelephone Interpersonal CounselingTelephone delivered 8 week education and counseling intervention based on interpersonal psychotherapy.
BEHAVIORALTelephone delivered education onlyTelephone delivered 8 week educational intervention on prostate cancer health, side effects, physical activity, diet, smoking cessation

Timeline

Start date
2006-09-01
Primary completion
2009-09-01
Completion
2009-10-01
First posted
2009-01-14
Last updated
2018-05-11
Results posted
2016-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00822510. Inclusion in this directory is not an endorsement.